DaVita Inc. (0I7E.L)
USD 145.65
(-2.14%)
USD 145.65
(-2.14%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 14.87 Billion USD | 1.17% |
| 2022 | 14.7 Billion USD | -0.32% |
| 2021 | 14.75 Billion USD | 4.67% |
| 2020 | 14.09 Billion USD | 2.03% |
| 2019 | 13.81 Billion USD | -1.89% |
| 2018 | 14.07 Billion USD | 7.87% |
| 2017 | 13.05 Billion USD | 1.03% |
| 2016 | 12.91 Billion USD | 3.07% |
| 2015 | 12.53 Billion USD | 6.65% |
| 2014 | 11.75 Billion USD | -0.37% |
| 2013 | 11.79 Billion USD | 2.27% |
| 2012 | 11.53 Billion USD | 74.13% |
| 2011 | 6.62 Billion USD | 9.0% |
| 2010 | 6.07 Billion USD | 13.3% |
| 2009 | 5.36 Billion USD | 3.8% |
| 2008 | 5.16 Billion USD | 2.11% |
| 2007 | 5.06 Billion USD | -1.22% |
| 2006 | 5.12 Billion USD | -4.06% |
| 2005 | 5.34 Billion USD | 175.91% |
| 2004 | 1.93 Billion USD | 20.57% |
| 2003 | 1.6 Billion USD | -4.4% |
| 2002 | 1.67 Billion USD | 47.52% |
| 2001 | 1.13 Billion USD | -7.33% |
| 2000 | 1.22 Billion USD | -28.07% |
| 1999 | 1.7 Billion USD | 21.08% |
| 1998 | 1.41 Billion USD | 250.41% |
| 1997 | 402.5 Million USD | 190.82% |
| 1996 | 138.4 Million USD | 77.66% |
| 1995 | 77.9 Million USD | -24.52% |
| 1994 | 103.2 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 14.6 Billion USD | -1.31% |
| 2024 Q3 | 15.28 Billion USD | 4.68% |
| 2024 Q1 | 14.79 Billion USD | -0.55% |
| 2023 Q4 | 14.87 Billion USD | 5.47% |
| 2023 FY | 14.87 Billion USD | 1.17% |
| 2023 Q2 | 14.32 Billion USD | 0.14% |
| 2023 Q1 | 14.3 Billion USD | -2.68% |
| 2023 Q3 | 14.1 Billion USD | -1.57% |
| 2022 Q3 | 14.88 Billion USD | -0.34% |
| 2022 Q4 | 14.7 Billion USD | -1.25% |
| 2022 FY | 14.7 Billion USD | -0.32% |
| 2022 Q1 | 14.67 Billion USD | -0.49% |
| 2022 Q2 | 14.93 Billion USD | 1.78% |
| 2021 Q4 | 14.75 Billion USD | -0.88% |
| 2021 FY | 14.75 Billion USD | 4.67% |
| 2021 Q1 | 14.86 Billion USD | 5.49% |
| 2021 Q2 | 14.92 Billion USD | 0.38% |
| 2021 Q3 | 14.88 Billion USD | -0.26% |
| 2020 Q2 | 15.72 Billion USD | 10.5% |
| 2020 Q1 | 14.23 Billion USD | 3.06% |
| 2020 Q3 | 13.98 Billion USD | -11.06% |
| 2020 Q4 | 14.09 Billion USD | 0.73% |
| 2020 FY | 14.09 Billion USD | 2.03% |
| 2019 Q2 | 14.5 Billion USD | -16.54% |
| 2019 Q1 | 17.37 Billion USD | 23.44% |
| 2019 Q3 | 13.64 Billion USD | -5.92% |
| 2019 Q4 | 13.81 Billion USD | 1.24% |
| 2019 FY | 13.81 Billion USD | -1.89% |
| 2018 Q1 | 13.12 Billion USD | 0.57% |
| 2018 FY | 14.07 Billion USD | 7.87% |
| 2018 Q4 | 14.07 Billion USD | -1.31% |
| 2018 Q3 | 14.26 Billion USD | 2.59% |
| 2018 Q2 | 13.9 Billion USD | 5.93% |
| 2017 Q4 | 13.05 Billion USD | 0.26% |
| 2017 FY | 13.05 Billion USD | 1.03% |
| 2017 Q1 | 13.06 Billion USD | 1.16% |
| 2017 Q2 | 13.06 Billion USD | -0.06% |
| 2017 Q3 | 13.01 Billion USD | -0.33% |
| 2016 FY | 12.91 Billion USD | 3.07% |
| 2016 Q4 | 12.91 Billion USD | 0.65% |
| 2016 Q3 | 12.83 Billion USD | 0.3% |
| 2016 Q2 | 12.79 Billion USD | 0.92% |
| 2016 Q1 | 12.67 Billion USD | 1.16% |
| 2015 FY | 12.53 Billion USD | 6.65% |
| 2015 Q1 | 12.34 Billion USD | 5.06% |
| 2015 Q3 | 12.8 Billion USD | 0.54% |
| 2015 Q4 | 12.53 Billion USD | -2.12% |
| 2015 Q2 | 12.73 Billion USD | 3.15% |
| 2014 Q3 | 12.19 Billion USD | -0.14% |
| 2014 FY | 11.75 Billion USD | -0.37% |
| 2014 Q2 | 12.2 Billion USD | 2.87% |
| 2014 Q1 | 11.86 Billion USD | 0.61% |
| 2014 Q4 | 11.75 Billion USD | -3.6% |
| 2013 Q2 | 11.57 Billion USD | -2.35% |
| 2013 Q4 | 11.79 Billion USD | 0.23% |
| 2013 FY | 11.79 Billion USD | 2.27% |
| 2013 Q3 | 11.76 Billion USD | 1.69% |
| 2013 Q1 | 11.85 Billion USD | 2.75% |
| 2012 Q3 | 8.15 Billion USD | 20.85% |
| 2012 Q1 | 6.75 Billion USD | 1.98% |
| 2012 FY | 11.53 Billion USD | 74.13% |
| 2012 Q4 | 11.53 Billion USD | 41.46% |
| 2012 Q2 | 6.74 Billion USD | -0.12% |
| 2011 FY | 6.62 Billion USD | 9.0% |
| 2011 Q4 | 6.62 Billion USD | -0.0% |
| 2011 Q3 | 6.62 Billion USD | 6.05% |
| 2011 Q2 | 6.24 Billion USD | 0.98% |
| 2011 Q1 | 6.18 Billion USD | 1.79% |
| 2010 Q2 | 5.22 Billion USD | -2.83% |
| 2010 Q1 | 5.37 Billion USD | 0.17% |
| 2010 Q3 | 5.25 Billion USD | 0.57% |
| 2010 Q4 | 6.07 Billion USD | 15.74% |
| 2010 FY | 6.07 Billion USD | 13.3% |
| 2009 Q4 | 5.36 Billion USD | -0.65% |
| 2009 Q1 | 5.31 Billion USD | 2.78% |
| 2009 Q2 | 5.09 Billion USD | -4.05% |
| 2009 Q3 | 5.39 Billion USD | 5.95% |
| 2009 FY | 5.36 Billion USD | 3.8% |
| 2008 FY | 5.16 Billion USD | 2.11% |
| 2008 Q1 | 5.04 Billion USD | -0.36% |
| 2008 Q2 | 5.1 Billion USD | 1.33% |
| 2008 Q3 | 5.1 Billion USD | -0.15% |
| 2008 Q4 | 5.16 Billion USD | 1.28% |
| 2007 FY | 5.06 Billion USD | -1.22% |
| 2007 Q4 | 5.06 Billion USD | 1.1% |
| 2007 Q1 | 5.05 Billion USD | -1.31% |
| 2007 Q2 | 5.03 Billion USD | -0.38% |
| 2007 Q3 | 5 Billion USD | -0.61% |
| 2006 Q4 | 5.12 Billion USD | 0.75% |
| 2006 Q3 | 5.08 Billion USD | -2.02% |
| 2006 Q2 | 5.19 Billion USD | 1.12% |
| 2006 Q1 | 5.13 Billion USD | -3.88% |
| 2006 FY | 5.12 Billion USD | -4.06% |
| 2005 Q4 | 5.34 Billion USD | 164.35% |
| 2005 Q3 | 2.02 Billion USD | 1.12% |
| 2005 FY | 5.34 Billion USD | 175.91% |
| 2005 Q2 | 1.99 Billion USD | 1.22% |
| 2005 Q1 | 1.97 Billion USD | 1.97% |
| 2004 Q3 | 1.93 Billion USD | 19.01% |
| 2004 FY | 1.93 Billion USD | 20.57% |
| 2004 Q1 | 1.62 Billion USD | 1.12% |
| 2004 Q4 | 1.93 Billion USD | 0.1% |
| 2004 Q2 | 1.62 Billion USD | 0.09% |
| 2003 FY | 1.6 Billion USD | -4.4% |
| 2003 Q4 | 1.6 Billion USD | -8.7% |
| 2003 Q3 | 1.75 Billion USD | -5.59% |
| 2003 Q2 | 1.86 Billion USD | 1.16% |
| 2003 Q1 | 1.84 Billion USD | 9.63% |
| 2002 Q3 | 1.69 Billion USD | 2.86% |
| 2002 Q4 | 1.67 Billion USD | -1.04% |
| 2002 Q2 | 1.64 Billion USD | 43.9% |
| 2002 Q1 | 1.14 Billion USD | 0.71% |
| 2002 FY | 1.67 Billion USD | 47.52% |
| 2001 Q4 | 1.13 Billion USD | -1.39% |
| 2001 FY | 1.13 Billion USD | -7.33% |
| 2001 Q3 | 1.15 Billion USD | -6.56% |
| 2001 Q1 | 1.21 Billion USD | -0.97% |
| 2001 Q2 | 1.23 Billion USD | 1.55% |
| 2000 Q1 | 1.66 Billion USD | -2.33% |
| 2000 Q3 | 1.32 Billion USD | -12.78% |
| 2000 Q4 | 1.22 Billion USD | -7.21% |
| 2000 Q2 | 1.51 Billion USD | -9.01% |
| 2000 FY | 1.22 Billion USD | -28.07% |
| 1999 Q1 | 1.5 Billion USD | 7.0% |
| 1999 Q4 | 1.7 Billion USD | 1.12% |
| 1999 Q3 | 1.68 Billion USD | 5.4% |
| 1999 FY | 1.7 Billion USD | 21.08% |
| 1999 Q2 | 1.6 Billion USD | 6.18% |
| 1998 Q4 | 1.41 Billion USD | 10.52% |
| 1998 Q1 | 1.04 Billion USD | 159.8% |
| 1998 Q3 | 1.27 Billion USD | 10.26% |
| 1998 FY | 1.41 Billion USD | 250.41% |
| 1998 Q2 | 1.15 Billion USD | 10.68% |
| 1997 Q1 | 139 Million USD | 0.43% |
| 1997 Q2 | 228.6 Million USD | 64.46% |
| 1997 Q3 | 285.5 Million USD | 24.89% |
| 1997 Q4 | 402.5 Million USD | 40.98% |
| 1997 FY | 402.5 Million USD | 190.82% |
| 1996 FY | 138.4 Million USD | 77.66% |
| 1996 Q4 | 138.4 Million USD | 25.02% |
| 1996 Q2 | 83 Million USD | -39.33% |
| 1996 Q1 | 136.8 Million USD | 31.92% |
| 1996 Q3 | 110.7 Million USD | 33.37% |
| 1995 Q2 | 103.2 Million USD | 0.0% |
| 1995 Q3 | 118.1 Million USD | 14.44% |
| 1995 FY | 77.9 Million USD | -24.52% |
| 1995 Q4 | 103.7 Million USD | -12.19% |
| 1994 FY | 103.2 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Phreesia, Inc. | 119.63 Million USD | -12334.49% |
| Accuray Incorporated | 423.54 Million USD | -3412.306% |
| Align Technology, Inc. | 2.45 Billion USD | -506.35% |
| Elevance Health Inc. | 69.52 Billion USD | 78.603% |
| AxoGen, Inc. | 101.16 Million USD | -14605.252% |
| Boston Scientific Corporation | 15.6 Billion USD | 4.677% |
| CVS Health Corporation | 173.09 Billion USD | 91.406% |
| Cardinal Health, Inc. | 48.33 Billion USD | 69.222% |
| Centene Corporation | 58.68 Billion USD | 74.651% |
| HCA Healthcare, Inc. | 55.15 Billion USD | 73.027% |
| Hologic, Inc. | 4.02 Billion USD | -269.501% |
| Humana Inc. | 30.74 Billion USD | 51.618% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | -737.905% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | -68.385% |
| Masimo Corporation | 1.67 Billion USD | -787.227% |
| McKesson Corporation | 69.04 Billion USD | 78.454% |
| Patterson Companies, Inc. | 1.89 Billion USD | -685.02% |
| Quest Diagnostics Incorporated | 7.6 Billion USD | -95.636% |
| ResMed Inc. | 2 Billion USD | -640.714% |
| Henry Schein, Inc. | 5.42 Billion USD | -174.467% |
| Teladoc Health, Inc. | 2.06 Billion USD | -619.942% |
| Universal Health Services, Inc. | 8.15 Billion USD | -82.419% |
| Veeva Systems Inc. | 1.26 Billion USD | -1074.96% |
| Baxter International Inc. | 19.8 Billion USD | 24.898% |
| Becton, Dickinson and Company | 26.98 Billion USD | 44.871% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | -627.724% |
| Danaher Corporation | 30.99 Billion USD | 52.009% |
| Stryker Corporation | 21.31 Billion USD | 30.221% |
| Medtronic plc | 39.56 Billion USD | 62.397% |